Amgen, a Thousand Oaks, Calif.-based biopharmaceutical company, will partner with Generate Biomedicines for a research collaboration agreement to discover and create five protein therapeutics for clinical targets.
Read the full post on Becker's Hospital Review - Healthcare News
